Table 5 Relationship between baseline Lp-PLA2 and gender, smoking, hypertension, diabetes, and ease of treatment
Parameter | Lp-PLA2 (ng/ml) | t-test or ANOVA | ||||
|---|---|---|---|---|---|---|
t or F | p | |||||
Gender | Male (n = 55) | 358.018 ± 77.133 | 5.832 | <0.001 | ||
Female (n = 35) | 271.8 ± 51.467 | |||||
Smoking | Smoker (n = 18) | 444.833 ± 26.425 | 10.83 | <0.001 | ||
Non-smoker (n = 72) | 294.403 ± 57.237 | |||||
Hypertension | Hypertensive (n = 15) | 396.8 ± 69.548 | 4.17 | <0.001 | ||
Normotensive (n = 75) | 310.027 ± 74.298 | |||||
Diabetes | Diabetic (n = 7) | 398 ± 51.095 | 5.171 | 0.008† | D&P | 0.440‡ |
Pre-diabetic (n = 13) | 353.923 ± 86.238 | D&N | 0.015‡ | |||
Non-diabetic (n = 70) | 311.671 ± 76.597 | P&N | 0.167‡ | |||
Ease of treatment | Easy to treat (n = 45) | 301.444 ± 78.506 | −2.837 | 0.006 | ||
Difficult to treat (n = 45) | 347.533 ± 75.582 | |||||